http://sci-hub.bz/http://onlinelibrary.wiley.com/doi/10.1111...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647647/ for more.
In general, placebo controlled trials are usually conducted for diseases which don't have an effective standard of care, or for conditions which aren't serious enough to be considered life threatening. For more serious diseases where a standard of care exists (standard of care is usually scientifically discovered but validated by placebo controlled trials), you conduct trials and compare the performance of the new drug/therapy with the existing standard of care as the control group.
More familiar than you apparently, because placebos have been proven to work:
https://www.medscape.com/viewarticle/853175
I think the problem is the subjective measure, so it's impossible to know which symptoms are caused by c.diff and which from IBS.
Also, given that the placebo improvement rates are 40-90% in all c.diff trials, it would be unethical to not use a placebo arm.
http://annals.org/aim/article-abstract/2545886/effect-fecal-...
I'm not terribly impressed by that approach.
I got up out of bed, posted a comment and was going to look for the link later if people asked. (I did a quick search and didn't find it). However, from the comments here, it's pretty clear people aren't interested in the science. Carry on...
"There have been a total of 2 placebo-controlled trials into fecal transplants for C.Diff AFAIK. One showed some benefit over placebo, and the other showed no difference."
1. What I already mentioned above regarding the conflicting results of these two placebo controlled trials
2. The studies used in the nhs article are all done for patients that we're currently undergoing treatment for c diff, not after a long treatment time.
3. Meta analyses and systematic reviews are always going to be higher powered statistically speaking. As long as the papers looked at don't stink of publication bias it's a very valid way of looking at all the research done on fecal transplants for c diff.
I would definitely trust a small negative placebo controlled trial over a large meta-analysis that didn't include any placebo controlled trials, especially for a treatment that has a 90% placebo responder rate (as the trial posted by elsherbini shows).